Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Conditions

• Inflammatory Bowel Diseases

Interventions

• DRUG: 24mg bid TQH3906 capsule
• DRUG: 32mg TQH3906 capsule
• DRUG: TQH3906 placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.